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The Effect of Aromatic Hydrocarbon Receptor 
on the Phenotype of the Hepa 1c1c7 Murine Hepatoma Cells 
in the Absence of Dioxin
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University of California, Los Angeles, California 90095, U.S.A.
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Abstract: The aromatic hydrocarbon receptor (AhR) mediates biological responses to certain exogenous ligands, such as 
the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and has also been demonstrated to modulate 
the cell cycle and differentiated state of several cell lines independently of exogenous ligands. In this study, we used DNA 
micorarray analysis to elucidate the profi le of genes responsive to the expression of unliganded AhR by re-introducing AhR 
into an AhR-defi cient mouse derivative (c19) of the mouse hepatoma cell line Hepa1c1c7. 22 gene products were 
up-regulated and 8 were down-regulated two-fold or more in c19 cells infected with a retroviral vector expressing mouse 
AhR.  Surprisingly, expression of genes involved in cell proliferation or differentiation were not affected by introduction 
of AhR. AhR also did not restore expression of the albumin gene in c19 cells.  Introduction of AhR into c12, a similar AhR-
defective mouse hepatoma cell line, also did not restore albumin expression, and furthermore, did not lead to changes in 
cellular morphology or cell cycle parameters.  These observations fail to support the notion that unliganded AhR regulates 
proliferation and differentiation of liver-derived cells.
Keywords: albumin; aromatic hydrocarbon receptor (AhR); cell cycle; Cyp1a1; DNA microarray; morphology.
Introduction
2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) elicits a variety of toxic, teratogenic, and carcinogenic 
responses in exposed animals and in humans (DeVito and Birnbaum, 1994). In certain cultured cells, 
TCDD shows marked effects on the regulation of cell cycle progression and terminal differentiation. 
It also induces thymocyte apoptosis, keratinocyte proliferation, and inhibition of estrogen-dependent 
proliferation in breast cancer cells (Milstone and LaVigne, 1984; Wiebel et al. 1991; Gaido et al. 1992; 
Safe 1995).
It is widely accepted that most, if not all effects of dioxins are mediated by a cytosolic receptor 
known as the aryl hydrocarbon receptor (AhR). AhR is a ligand-activated transcription factor that forms 
a transcriptionally active heterodimer with the aryl hydrocarbon nuclear translocator (ARNT) (Hoffman 
et al. 1991; Reyes, 1992). In the cytosol, the unliganded AHR is found in a complex with two HSP90 
molecules, the co-chaperone protein p23, and the hepatitis B virus X-associated protein 2 (XAP2) 
(Meyer et al. 1998; Kazlauskas et al. 1999). Ligand binding disrupts this complex and causes nuclear 
translocation of the AHR. The nuclear AHR/ARNT heterodimer binds to 5’-CACGCNA/C-3’ DNA 
motifs (termed DREs or XREs) in the regulatory regions of the CYP1A1, CYP1B1, CYP1A2 and CYP2S1 
cytochrome P450 genes, and several genes coding for phase II detoxifi cation enzymes, such as glutathione 
S-transferase, NAD(P)H-dependent quinone oxidoreductase-1, aldehyde dehydrogenase-3, and others, 
and activates their transcription (Sutter and Greenlee, 1992; Hankinson, 1995; Rivera et al. 2007).
AhR has been reported to associate with retinoblastoma (RB) both in vivo and in vitro, and synergizes 
with RB to repress E2F-dependent transcription and to induce cell cycle arrest in a number of cell lines, 
although the effects of AhR on the cell cycle vary in different reports (Puga et al. 2000a; Shimba et al. 
2002; Huang and Elferink, 2005). In mouse hepatoma Hepa lclc7 cells, in the absence of exogenous 
ligands, AhR was reported to accelerate cell proliferation, and modulate the differentiated state (Ma and 
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Whitlock, 1996). However, the mechanisms 
underlying the effects of unliganded AhR on cell 
proliferation and differentiation of Hepa 1c1c7 cells 
remain to be established. In this study, we re-
introduced AhR into an AhR-defective B mutant of 
Hepa 1c1c7 cells (Hankinson, 1983). The B mutants 
are defective in the expression of AhR mRNA, and 
have been hypothesized to be defective in the 
activity of a transcription factor or chromatin modi-
fi cation factor required for transcription of the AhR 
gene (Zhang et al. 1996). We then elucidated the 
profile of AhR-responsive genes using DNA 
microarray analysis. Furthermore, we studied the 
potential effects of AhR on the phenotype of the 
mouse hepatoma cells, including cell cycle, 
morphology and the expression of albumin.
Materials and Methods
Materials 
The plasmids pMFG-AhR and pCMMP-lacZ were 
kind gifts from Drs. James Whitlock and Richard 
C. Mulligan, respectively (Ma et al. 1996, Klein 
et al. 2000). 
Cell culture
Wild-type Hepa 1c1c7 and B mutants cells (c12 and 
c19) were grown in alpha minimal essential medium 
containing 10% fetal bovine serum (FBS).
Retrovirus preparation and infection 
293T cells were grown in DMEM with 10% FBS 
and penicillin/streptomycin. Cells were grown to 
50% confl uency in 10-cm dishes and transfected 
with the retroviral vectors and a packaging vector 
pCLeco using a standard calcium-phosphate 
method. The medium was replaced 24 h post-
transfection. The virus-containing supernatants 
were collected 36 and 48 h after transfection, 
fi ltered through a 0.45-µm syringe fi lter, and stored 
at 4 °C. For retroviral infection, B mutant cells 
(1.0 × 105/well) were seeded in six-well plates, and 
2 ml of virus supernatant containing 8 µg/ml of 
polybrene was added to the cells.
Gene chip analysis
Total RNA was extracted from each sample with 
the TRIzol Reagent (Invitrogen, Carlsbad, CA, 
U.S.A). Two weeks after infection, RNA was 
extracted from infected B mutant cells. The RNA 
was cleaned with RNeasy Mini Kit (Qiagen Inc., 
Valencia, CA, U.S.A.). RNA from c19 cells 
infected with pMFG-AhR or pCMMP-LacZ was 
converted to biotinylated cRNA (Bioarray High 
Yield RNA Transcription Labeling Kit; Enzo Diag-
nostics, Farmingdale, NY, U.S.A.) according to the 
manufacturer’s protocols. Following fragmentation 
and quality confi rmation with the Affymetrix Test3 
Array, each biotinylated cRNA was hybridized to 
a  Mouse Genome U74Av2 chips from Affymetrix 
(Santa Clara, CA), containing a total of 12,488 
probe sets. Following hybridization, each chip was 
washed, stained with streptavidin-phycoerythrin, 
and scanned with a probe array scanner. Microarray 
expression data were generated with Affymetrix 
Microarray Suite 5.0 software.
Data analysis 
Microarray expression data were analyzed with 
DNA-Chip Analyzer (dChip) version 1.3 (Li and 
Wong, 2003). Gene expression results from 
B-mutant cells infected with pCMMP-lacZ (Basal 
or B) or pMFG-AhR (Experimental or E) were 
normalized and compared, with each group 
containing the data obtained from a single chip. The 
‘Invariant Set Normalization’ method, which 
chooses a subset of probes with small rank differ-
ence in all arrays, was used to perform cross-chip 
normalization. Comparison was done by computing 
the expression fold-difference for each gene and 
listing those that show larger than 2.0 fold increase 
or decreases in activity. Genes with differences of 
expression levels (E-B or B-E) lower than 20 were 
excluded to get reliable fold-difference results. The 
gene categories were identifi ed from gene ontology 
using NIH DAVID (http://apps1.niaid.nih.gov/
david/).
Cell cycle analysis
The cells were trypsinized and suspended in PBS. 
An aliquot (1 × 106 cells) was placed into a 
centrifuge tube. After centrifugation, the cells were 
suspended and stained in 1 ml of hypotonic staining 
buffer (0.1% sodium citrate, 0.3% Triton-X 100, 
0.01% propidium iodide (PI), 0.002% ribonuclease 
A) for 30 minutes at 4 oC, and then subjected to 
fl ow cytometry using CellQuest software on LSRII 
cytometer (BD Biosciences). DNA content was 
determined using ModFit (Verity Software House, 
Topsham, ME).
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Reverse transcription and real-time 
PCR
Total RNA was prepared from the cells using the 
RNeasy Micro kit (Qiagen). 1.5 µg of total RNA was 
reverse-transcribed using a Super script III Reverse 
Transcriptase kit (Invitrogen). Real-time PCR 
was performed using the SYBR Green Master Mix 
(Applied Bio-Science). The primer sets for RT-PCR 
are as follows: 5’-AGGTGTGATGGTGGGAATGG-
3’, 5’-GCCTCGTCACCCACATAGGA-3’ for 
β-actin; 5’-AGATGCAGCCAGATCCGCAT -3’, 
5’-GTTCTTGCCCATCAGCACC -3’ for the ribo-
somal 36B4 gene; 5’-AGAAGGTCACTCTCTTTG-
GTTTGG-3’, 5’-GCAGCAAGATGGCCAGGAA-3’ 
for CYP1A1; 5’-CCGTGTGACTGGCATC-
GATTAT-3’, 5’-CATGCCACTGCCAACT-
TAGGAA-3’ for albumin.
Immunoblotting
Whole-cell lysates were prepared using lysis buffer 
(25 mM Hepes, PH 7.4, 1 mM EDTA, 400 mM 
NaCl, 1 mM DTT, and 1% Triton X-100) and 
resolved on 8% SDS polyacrylamide gel (50 μg/
lane). The AhR protein was detected in whole-cell 
extracts using a 1:1000 dilution of an immunoaf-
fi nity purifi ed rabbit polyclonal AhR antibody 
made in our laboratory.
Results
DNA microarray analysis 
of AhR-dependent gene expression
The B mutants were isolated in our laboratory 
by selecting for rare clones of Hepa lclc7 cells 
that survived the toxic effects of benzo(a)pyrene 
(Hankinson, 1979; Hankinson, 1983).  They are 
deficient in the expression of AhR (Zhang et al. 
1996). To search for the genes whose expression 
are mediated by AhR, we re-introduced AhR 
into c19 cells, one of the B mutants, using the 
retroviral vector, pMFG-AhR, containing mouse 
AhR (Ma et al. 1996). Infection efficiencies 
were tested by X-gal staining for expression of 
β-gal encoded by the lacZ gene in the control 
retroviral vector pCMMP-lacZ (Klein et al. 
2000), and reverse selection for expression of 
AhR contained in pMFG-AhR (Zhang et al. 
1996). (The pCMMP retroviral vector is derived 
from pMFG and the two vectors are very 
similar). Both types of retrovirus infected the B 
mutants with nearly 100% efficiency (data not 
shown). We confirmed the expression of the 
AhR protein in c19 infected with pMFG-AhR 
by Western blot analysis (Fig. 1). Of the total 
of 12,488 genes on the microarray chip, 5491 
genes were expressed in the B mutant cells. With 
DChip analysis, we identified 30 genes differ-
entially expressed by at least 2-fold in c19 cells 
infected with pCMMP-lacZ compared with 
those infected with pMFG-AhR (Table 1). 22 
genes were up-regulated and 8 genes were 
down-regulated by re-introduced AhR. These 
genes were clustered into stimulus response, 
metabolism, cell communication, and morpho-
genesis groups, based on the functions of their 
protein products. Interestingly, no genes in the 
cell cycle or differentiation clusters were 
affected by AhR expression. Cyp1a1, phospho-
lipase A2, NAD(P)H dehydrogenase quinone 1 
(NADPH quinone oxidoreductase 1), which are 
known to be regulated by TCDD treatment 
(Sutter and Greenlee, 1992; Hankinson, 1995; 
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Figure 1. Immunoblot for AhR. Proteins were extracted from whole cells and subjected to immunoblot analysis using an anti-AhR antibody 
prepared in our laboratory.
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Table 1. List of genes that respond to AhR.
Category Gene Accession fold
    changea
Stimulus 
Response defender against cell death 1 AV007196 –16.44
  killer cell lectin-like receptor, subfamily A, member 1 M25775 2.03
  killer cell lectin-like receptor, subfamily A, member 4 U10090 2.23
  secretory leukocyte protease inhibitor AF002719 –2.19
  chemokine (C-C motif) ligand 12 U50712 –2.29
  chemokine (C-X-C motif) ligand 1 J04596 –2.03
     
Metabolism cytochrome c oxidase, subunit IVa M37831 –2.11
  cytochrome P450, 1a1, aromatic compound inducible K02588 15.78
  mannosidase 1, alpha AI021125 2.21
  phospholipase A2, group IVA (cytosolic, calcium- M72394 2.17
 dependent)
  vanin 1 AJ132098 –2.75
  NAD(P)H dehydrogenase, quinone 1 U12961 2.2
  heparan sulfate (glucosamine) 3-O-sulfotransferase 1 AF019385 2.05
  chromobox homolog 1 (Drosophila HP1 beta) X56690 2.38
     
Cell Communication gap junction membrane channel protein alpha 1 M63801 2.19
  tachykinin receptor 1 X62934 19.74
     
Morphogenesis small proline-rich protein 2A AJ005559 –2.65
     
Other expressed sequence C79026 AI561567 2.18
  high mobility group AT-hook 1 AV311953 2.34
  zinc fi nger protein 62 Z67747 2.02
  T-cell receptor beta, joining region M20878 4.14
  ELL-related RNA polymerase II, elongation factor AI197161 2.6
  ESTs AI853048 2.23
  ESTs, Weakly similar to  down-regulated by Ctnnb1,  AI891514 2.59
  expressed sequence R74626 R74626 2.59
  RIKEN cDNA 2610007K22 gene AV291989 2.71
  RIKEN cDNA 2900024N03 gene AI508500 2.42
  RIKEN cDNA 5430432P15 gene AI265115 2.12
  RIKEN cDNA D730042P09 gene AV150572 –2.14
  DNA segment, Chr 3, Wayne State University 167,  AA408385 5.41
 expressed
The cDNA microarray data were analyzed to dertermine the number of genes that were up- and down-regulated by AhR.
a Positive fold induction represents the ratio of the signal obtained from c19 cells expressing ecotopic AhR divided by the signal obtained 
from the cells expressing lacZ. Negative fold induction ratios represent the signal obtained from c19 cells expressing lacZ divided by the 
signal obtained from the cells expressing ecotopic AhR.
Boverhof et al. 2006) but are poorly inducible 
by dioxin in B mutant cells comparing with 
wild-type Hepa 1c1c7 cells (our unpublished 
observations), were up-regulated by AhR. We 
confirmed the data for Cyp1a1 from the cDNA 
microarray using real time PCR. As shown 
in Figure 2A, Cyp1a1 was indeed up-regulated 
significantly by expressing AhR in c19 cells. 
Although DChip analysis did not show any 
change in expression of AhR, this is explained 
by the fact that pMFG-AhR expresses a mRNA 
for the coding region of AhR, and all the 16 
probes for AhR in the chip are designed to 
anneal to the 3’-UTR of the mRNA of AhR.
AhR did not up-regulate expression 
of albumin
The parental Hepa1c1c7 cells express albumin 
mRNA. However, we found that the mRNA level 
for albumin was too low to be detected even in c19 
cells forced to express AhR, as shown by DChip 
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analysis (data not shown). This was surprising 
since the expression of albumin was previously 
reported by Ma and Whitlock (Ma and Whitlock, 
1996) to be rescued by expressing exogenous AhR 
in an AhR-defi cient clone of Hepa1c1c7 cells 
equivalent to our B mutants. To investigate whether 
this findings is cell-specific, we infected c12, 
another B mutants cloned from Hepa1c1c7 cells 
(Hankinson, 1983), with pMFG-AhR and pCMMP-
lacZ, respectively. We confi rmed the expression of 
AhR in c12 cells infected with pMFG-AhR using 
Western blot analysis (Fig. 1). We quantified 
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Figure 2. Total RNA was isolated from the indicated cells and used for reverse transcription. The cDNAs were then subjected to real time 
PCR analysis. The result is an average from three real time PCR reactions with the same template. Standard deviations are shown. A, 
Expression of Cyp1a1. The mRNA levels of Cyp1a1 were normalized to that of the constitutively expressed 36B4 gene, encoding a ribo-
somal subunit. B, Detection of albumin mRNA. The mRNA levels of albumin were normalized to that of the constitutively expressed β-actin 
gene. Standard deviations are shown.
(B)
(A)
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mRNA of albumin in these cells and in the wild 
type Hepa1c1c7 cells using real time PCR and 
found that although the mRNA for albumin is 
readily detectable in Hepa1c1c7 cells, it was not 
detectable in c12 cells infected with either 
pCMMP-lacZ or pMFG-AhR (Fig. 2B), consistent 
with our cDNA microarray data.
Re-introduction of AhR into B mutants 
failed to change their morphology
The wild-type Hepa 1c1c7 cells express a partially 
differentiated liver phenotype. Phase-contrast 
microscopy reveals that Hepa1c1c7 cells are 
epithelioid and polygonal, contain multiple 
nucleoli, have a granular cytoplasm, and form an 
orderly monolayer at confl uence; these features are 
typical of hepatocytes. B mutants show morpho-
logical changes; for example, they appear less well 
differentiated and more spindle shaped, and they 
fail to form well-organized monolayers at high 
density (Fig. 3). These observations are similar to 
those made by Ma and Whitlock for their AhR-
defi cient derivatives.  Ma and Whitlock reported 
that re-introduction of AhR into AhR-D cells 
reverted their morphology to that of Hepa1c1c7 
cells. However, we did not observe any morpho-
logical changes in either c19 or c12 cells forced to 
express exogenous AhR. 
AhR showed little effects on the cell 
cycle of B mutants
To investigate if AhR affects the cell cycle of Hepa 
1c1c7 cells, we performed cell cycle analysis using 
c19 cells expressing ectopic AhR or lacZ. We used 
fl ow cytometry to determine whether AhR exerts 
an effect at a particular phase of the cell cycle. 
However, we did not fi nd any signifi cant difference 
in the duration of any phase of the cell cycle, 
comparing B mutants expressing AhR and those 
expressing lacZ, after analysis of unsynchronized 
populations during logarithmic growth (Table 2). 
We obtained similar results with cell cycle analysis 
of c12 cells expressing AhR or lacZ (data not 
shown). These results are consistent with the data 
from our DNA microarray analysis that failed to 
show any cell cycle-related genes regulated by 
C12/pCMMP-LacZ
C12/pMFG-AhR
C19/pCMMP-LacZ
C19/pMFG-AhR
Hepa 1c1c7
Figure 3. Morphology of wild-type, B mutants, and B mutants infected with pMFG-AhR and pCMMP-lacZ. The cells were cultured under 
normal conditions, visualized by phase contrast microscopy, and photographed
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AhR, implying that AhR has little effect on the cell 
cycle of the mouse hepatoma cells in the absence 
of TCDD.
Discussion
Recent studies using DNA microarray techniques 
suggested that approximately 300 genes were 
altered by TCDD-dependent AhR activation in the 
human hepatoma HepG2 cells (Puga et al. 2000b; 
Frueh et al. 2001). However, target genes for AhR 
in the absence of exogenous ligands remain 
unknown. Since AhR has been reported to modu-
late the phenotype of mouse hepatoma cells in the 
absence of exogenous ligands (Ma and Whitlock, 
1996), it was of interest to further elucidate the 
potential mechanisms by which AhR exerts its 
effects on the phenotype of cells, and to identify 
AhR target genes in the absence of exogenous 
ligands. In this study, we re-introduced AhR into 
c19 cells, a B mutant deficient for AhR, and 
compared the gene expression profi le of these cells 
with that of c19 cells with introduced lacZ. We 
identifi ed 30 genes that are differentially expressed 
at least 2-fold in the two cell types. These genes 
are clustered into stimulus response, metabolism, 
cell communication, and morphogenesis, based 
on the biological functions of their protein prod-
ucts. Interestingly, Cyp1a1, phospholipase A2, and 
NAD(P)H quinone oxidoreductase 1, which were 
previously shown to be regulated by TCDD treat-
ment, were up-regulated by AhR. We speculate 
that this result may be ascribed to “leaking 
through” of AhR into the nucleus, or activation of 
AhR by endogenous ligands. We previously 
provided evidence that the AhR is partially acti-
vated by ligands present in the medium in Hepa-1 
cells cultured in the absence of added ligand 
(Wang et al. 2004). To our knowledge, the other 
genes we identifi ed have not been reported to be 
induced by TCDD (Jin et al. 2004, Boverhof et al. 
2005, Boverhof et al. 2006, Dere E et al. 2006, 
Yoon et al. 2006). They therefore may represent 
novel target genes of unliganded AhR. Among 
these genes, six are involved in cell stimulus 
response, suggesting a role of AhR in such 
responses. Considering that suppression of the 
immune response by TCDD is largely mediated 
by AhR, it will be of interest to ascertain the 
potential relationship between the AhR-induced 
genes related to stimulus response and AhR- 
mediated immune repression. Since AhR is located 
in the cytoplasm in the absence of exogenous 
ligands, it is intriguing how genes can be induced 
by the un-liganded AhR. One possibility is that 
AhR transducts its signal into the nucleus via a 
factor (s) that translocates into the nucleus. 
Furthermore, our data suggest that, in the absence 
of suffi cient amounts of exogenous ligand, AhR 
can alter only a very limited number of genes and 
only to a very limited degree.
We further investigated whether AhR could 
change the phenotype of the cells. Introduction of 
AhR failed to alter the expression of albumin, cell 
morphology, or cell cycle parameters in our B 
mutant clones. This confl icts with the fi ndings 
made by Ma and Whitlock (Ma and Whitlock, 
1996). In their studies, they found that AhR 
restored the expression of albumin in AhR-D cells 
(equivalent to our B mutants) to the same level as 
that in wild type Hepa 1c1c7 cells, restored the 
morphology of AhR-D cells to the differentiated 
phenotype of the parental Hepa 1c1c7 cells, and 
reduced the length of the G1 phase of the cell cycle 
of the cells. It is possible that these discrepancies 
results from the fact that Ma and Whitlock 
transfected their AhR-D cells with an AhR-
expressing plasmid and picked a single colony for 
analysis. In contrast, we infected B mutant cells 
with a retroviral vector expressing AhR and used 
a pool of infected cells to perform our studies. 
Cells from a single colony may not be representa-
tive of the whole cell population, since certain 
cellular phenotypes can exhibit considerable clonal 
variation in culture.  It is conceivable that the AhR-
transfected clone studied by Ma and Whitlock 
coincidentally lost albumin expression and 
changed morphology via mechanisms unrelated to 
AhR. Secondly, the AhR-D cells and the B mutants 
were both isolated from wild type Hepa 1c1c7 
cells, but each represents an independent clone. 
Therefore, we cannot exclude the possibility that 
the effects of AhR on cell phenotype are dependent 
Table 2. Cell cycle analysisa.
Cell type Percentage of cells ± SD
 G1 (%): G2 (%): S (%):
C19/pCMMP-lacZ 50.2 ± 5.8 10.5 ± 0.7 39.3 ± 5.5
C19/pMFG-AhR 47.0 ± 2.9 11.0 ± 1.8 42.0 ± 1.2
aCells in mid-log phase were stained with propidium iodide, and the 
percentage of cells in each phase was determined by fl ow cytometry. 
The means and standard deviations were determined from three 
experiments. 
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on the properties of each individual clone. This 
possibility receives some support from the fi ndings 
that AhR exerts opposite effects on the cell cycle 
and the state of differentiation in different type of 
cells (Gudas and Hankinson, 1987; Puga et al. 
2000a; Shimba et al. 2002; Huang and Elferink, 
2005;). Nevertheless, in this study, we conclude 
that AhR, in the absence of suffi cient amounts of 
exogenous ligands, has little effect on the 
proliferation or state of differentiation of mouse 
hepatoma cells.
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